Xiangxiang Zhou

No. 324, Jingwu Road
Jinan, 250021, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 72 publications

In vivo CAR-T therapy: latest updates from the 2025 ASH annual meeting.

In vivo CAR-T therapy: latest updates from the 2025 ASH annual meeting.

Journal: Biomarker research

Published: February 22, 2026

Dual-target CAR-T cell therapy: latest updates from the 2025 ASH annual meeting.

Dual-target CAR-T cell therapy: latest updates from the 2025 ASH annual meeting.

Journal: Experimental hematology & oncology

Published: February 21, 2026

Remodeling of Mitochondrial Networks: Cellular Adaptation and Microenvironmental Reprogramming in Hematologic Malignancies.

Remodeling of Mitochondrial Networks: Cellular Adaptation and Microenvironmental Reprogramming in Hematologic Malignancies.

Journal: Blood cancer discovery

Published: September 07, 2025

Recent advances in S-palmitoylation and its emerging roles in human diseases.

Recent advances in S-palmitoylation and its emerging roles in human diseases.

Journal: Journal of hematology & oncology

Published: May 28, 2025

Causal links between gut microbiota, metabolites, and diffuse large B-cell lymphoma: Evidence from a Mendelian randomization study.

Causal links between gut microbiota, metabolites, and diffuse large B-cell lymphoma: Evidence from a Mendelian randomization study.

Journal: Advances in clinical and experimental medicine : official organ Wroclaw Medical University

Published: March 09, 2025

CAR-NK cell therapy: latest updates from the 2024 ASH annual meeting.

CAR-NK cell therapy: latest updates from the 2024 ASH annual meeting.

Journal: Journal of hematology & oncology

Published: January 10, 2025

A highly selective and orally bioavailable casein kinase 1 alpha degrader through p53 signaling pathway targets B-cell lymphoma cells.

A highly selective and orally bioavailable casein kinase 1 alpha degrader through p53 signaling pathway targets B-cell lymphoma cells.

Journal: Leukemia

Published: January 09, 2025

The Expanded Side-Chain Conjugation Strategy Markedly Improves the Third-Order Nonlinear Optical Performance of Triazine-Based Covalent Organic Frameworks.

The Expanded Side-Chain Conjugation Strategy Markedly Improves the Third-Order Nonlinear Optical Performance of Triazine-Based Covalent Organic Frameworks.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: December 12, 2024

Exosome- transported FER inhibitor suppresses progression of diffuse large B-cell lymphoma via regulating AJUBA/Hippo axis.

Exosome- transported FER inhibitor suppresses progression of diffuse large B-cell lymphoma via regulating AJUBA/Hippo axis.

Journal: NPJ precision oncology

Published: December 07, 2024

Autoimmune disease and risk of lymphoma: analysis from real-world data and Mendelian randomization study.

Autoimmune disease and risk of lymphoma: analysis from real-world data and Mendelian randomization study.

Journal: BMC cancer

Published: November 22, 2024

Targeting TTK Inhibits Tumorigenesis of T-Cell Lymphoma Through Dephosphorylating p38α and Activating AMPK/mTOR Pathway.

Targeting TTK Inhibits Tumorigenesis of T-Cell Lymphoma Through Dephosphorylating p38α and Activating AMPK/mTOR Pathway.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: October 30, 2024

Amino Acid Metabolism-Related Gene Kynureninase (KYNU) as a Prognostic Predictor and Regulator of Diffuse Large B-Cell Lymphoma.

Amino Acid Metabolism-Related Gene Kynureninase (KYNU) as a Prognostic Predictor and Regulator of Diffuse Large B-Cell Lymphoma.

Journal: Biochemical genetics

Published: October 17, 2024

Showing 1-12 of 72

Last Updated: 09/26/2026